о колледже
план приёма
специальности
живопись
менеджмент
звукотехника
фотография
абитуриентам
живопись
менеджмент
звукотехника
фотография
экзамены
история
литература
математика
физика
химия
преподаватели
ссылки
контакты
новости

Наша поддержка:
© 2009-2012 ФГОУ ВППО ВГИК им. С.А. Герасимова

Manufacturer antibiotic “Bioparox” ceases production of the drug due to “rare cases that led to death”

Manufacturers antibiotic “Bioparox” - French pharmaceutical company “Laboratory Servier” - ceases to manufacture preparatav due to “rare cases that led to death.” A letter was sent to the Federal Service for Supervision in the Sphere of Health.

What happened with the drug “Bioparox” - why it was banned. It turns out “Bioparox” in the near future will be denied - the company Servier has decided to withdraw from the sale of spray for the throat “Bioparox” (fusafungine) across the globe, according to Pharmaceutical Review of Kazakhstan, reports therussiantimes.com.

According to this publication, the paper also reported on the “rare cases leading to death.” In addition to the letter Roszdravnadzor said that the decision to revoke the permits for the use of drugs containing fusafungine, was made in response to concerns “about Po serious hypersensitivity reactions occurring in some patients.”

Complications were serious - an investigation into the preparation began immediately. It is reported that the patients who used the aerosol were reported rare, but life-threatening complications. From now on, “Bioparox” active substance is a polypeptide antibiotic fusafungine will not be sold in any of the countries of the world. Recall that this drug helps in diseases such as sinusitis, rhinitis, nasopharyngitis, tonsillitis and laryngitis.

Experts are concerned that the use of drugs may well be a prerequisite of antibiotic resistance. Although there is no direct evidence for this, but there is a risk, experts say. At the same time, we recall that the drug was sold in several EU countries, for at least 50 years.

Recall that this drug helps in diseases such as sinusitis, rhinitis, nasopharyngitis, tonsillitis and laryngitis. Experts are concerned that the use of drugs may well be a prerequisite of antibiotic resistance. Although there is no direct evidence for this, but there is a risk, experts say.

“Bioparox” administered and used as an antiseptic and antibacterial agent in infectious diseases of the upper respiratory tract, such as nasopharyngitis. The investigation of this drug started when patients used the spray were reported rare, but life-threatening, according to doctors, complications. Now patients who are accustomed to the drug, pharmacists strongly recommend to stop its use.

26 April 2016

««« The best Latvian students awarded scholarships Mayor VII Eurasian Economic Youth Forum »»»

Roszdravnadzor recommends complain about the quality of the medicines your doctor »»»
Independently the patient is not able to distinguish quality from poor-quality drug, said the head of department Michael Murashko MOSCOW, 23 May.
Recovery of the body without medication. »»»
In order to live long, you need to give your body the vitamins, minerals and amino acids which are not in our typical diet.
BIOCAD first Russian pharmaceutical companies applied for participation in the public investment contracts »»»
Biotechnology company BIOCAD first time in the history of Russian pharmaceutical industry has applied to enter into a special investment contract (SPIC).
Auction for the purchase of a set of "Beyodaym" in Sevastopol canceled for the FAS decision »»»
Office of the Federal Antimonopoly Service of the Republic of
Russia will create its own method of assessing the quality of foreign universities »»»
At present diplomas from foreign universities are recognized only on a reciprocal basis and not on the level of individual schools, and at the country level.